PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Aug 2017; 67(2): 370-398 Pubmed [7930]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Aug 2018; 69(2): 461-511 Pubmed [7936]
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. J Hepatol. Jan 2017; 66(1): 153-194 Pubmed [7929]
Euwema MS. . Mar 2021 Pubmed [10783]
Evanger N. Can J Hosp Pharm. Nov 2017; 70(6): 463-467 Pubmed, Volltext [4957]
Evans DC. Drug Metab Dispos. Jul 2003; 31(7): 861-9 Pubmed [4640]
Evans JL. Diabetes Technol Ther. Oct 2000; 2(3): 401-13 Pubmed [11729]
Evans RL. J Clin Psychopharmacol. Oct 1990; 10(5): 355-9 Pubmed [485]
Evans RW. Headache. Jun 2010; 50(6): 1089-99 Pubmed [992]
Evans RW. MedGenMed. Sep 2007; 9(3): 48 Pubmed, Volltext [1323]
Evans SG. Trans R Soc Trop Med Hyg. Nov 1994; 88(6): 683-6 Pubmed [8722]
Evans-Prosser CD. Br J Anaesth. Apr 1968; 40(4): 279-82 Pubmed [13116]
Evers S. Eur J Neurol. Jun 2006; 13(6): 560-72 Pubmed [8475]
Evidente VG. Parkinsonism Relat Disord. Dec 2003; 10(2): 117-21 Pubmed [10437]
Evins AE. J Clin Psychopharmacol. Aug 2007; 27(4): 380-6 Pubmed [10303]
Exeltis Deutschland GmbH, Ismaning/Deutschland, Fachinformation zu XONVEA TM 10 mg/10 mg magensaftresistente Tabletten.Feb 2022 [13475]
Eyer F. Alcohol Alcohol. Mar 2011; 46(2): 177-84 Pubmed [1013]
Eyer F. J Clin Psychopharmacol. Jun 2006; 26(3): 325-30 Pubmed [9776]
Ezad S. Oxf Med Case Reports. Mar 2018; 2018(3): omx104 Pubmed, Volltext, DOI [6989]
Ezuruike U. Clin Pharmacol Ther. Dec 2018; 104(6): 1229-1239 Pubmed, Volltext, DOI [8229]
Ezzeldin N. BMC Cancer. May 2018; 18(1): 525 Pubmed, Volltext, DOI [5081]
Faaij RA. J Nutr Health Aging. Mar 2009; 13(3): 275-6 Pubmed [1687]
Fabbiani M. Pharmacol Res. Mar 2011; 63(3): 249-53 Pubmed [7359]
Fabbri M. Drugs Aging. Dec 2018; 35(12): 1041-1054 Pubmed [12211]
Fabbri M. Mov Disord. Oct 2018; 33(10): 1528-1539 Pubmed [12196]
Fabbri M. Neurodegener Dis Manag. Oct 2016; 6(5): 349-62 Pubmed [12202]
Faber ES. Drug Saf Case Rep. Dec 2016; 3(1): 14 Pubmed, Volltext, Springer [8020]
Faber MS. Basic Clin Pharmacol Toxicol. Sep 2005; 97(3): 125-34 Pubmed [3167]
Faber MS. Clin Pharmacol Ther. Aug 2004; 76(2): 178-84 Pubmed [429]
Facciolá G. Eur J Clin Pharmacol. Mar 2001; 56(12): 881-8 Pubmed [13993]
Facciolà G. Ther Drug Monit. Jun 1999; 21(3): 341-5 Pubmed [1210]
Fachi MM. Br J Clin Pharmacol. Oct 2019; 85(10): 2280-2291 Pubmed [11214]
Fachinfo Dezember 1999 [2047]
Fachinfo EMB-Fatol® [3429]
Fachinfo Noxafil (Posaconazol) [4112]
Fachinfo Phenytoin AWD 01/2009, bei Abfassung jüngste Fachinfo zu Phenytoin [2135]
Fachinfo Prezista® [3426]
Fachinfo Pyrafat® [3430]
Fachinfomation Norvasc®, Stand der Information, Oktober 2011 [3472]
Fachinforamtion Tranylcypromin 2007 [2354]
Fachinformaation Oxygesic®, Stand März 2010 [174]
Fachinformatin Sifrol April 2009 [2898]
Fachinformation [188]
Fachinformation (Glivec), Oktober 2002 [2177]
Fachinformation 04/2001 [1415]
Fachinformation 04/2002 [2123]
Fachinformation 05/2002 [2490]
Fachinformation 06/2002 [1117]
Fachinformation 08/2008 [1445]
Fachinformation 2000 [1829]
Fachinformation 2002 [570]
Fachinformation 2007 [2627]
Fachinformation Abilify [582]
Fachinformation Abilify. Stand Mar 2022. [12628]
Fachinformation Abilify. Stand Oct 2019. [8814]
Fachinformation Abilify. Stand Oct 2020. [9748]
Fachinformation Abilify®, Stand der Information März 2008 [2756]
Fachinformation Abilify®, Stand der Information Nov. 2012 [3512]
Fachinformation Acc. Stand Feb 2015. [8294]
Fachinformation Acc. Stand Jun 2019. [8471]
Fachinformation Accupro. [10264]
Fachinformation Accupro. Stand Jul 2019. [10248]
Fachinformation Accupro. Stand Jul 2021. [11930]
Fachinformation Accupro. Stand Mar 2022. [12149]
Fachinformation Accupro. Stand May 2021. [10985]
Fachinformation Accupro. Stand Nov 2023. [13713]
Fachinformation Aciclovir-ratiopharm. Stand Oct 2013. [5398]
Fachinformation Adalat. Stand Jul 2016. [9224]
Fachinformation Adempas. Stand Feb 2019. [7724]
Fachinformation Adenosin Altamedics. [8287]
Fachinformation Adenosin Altamedics. Stand Jun 2018. [8288]
Fachinformation Adenuric. [12781]
Fachinformation Aerius. Stand Feb 2025. [14260]
Fachinformation Aerius. Stand Jun 2018. [7838]
Fachinformation Aggrenox. Stand Feb 2015. [7564]
Fachinformation Aggrenox. Stand Jun 2015. [8289]
Fachinformation Agnucaston. Stand Mar 2022. [13638]
Fachinformation Agopton. Stand Jan 2021. [10422]
Fachinformation Aimovig. Stand Aug 2023. [13496]
Fachinformation Ajovy. Stand Nov 2023. [13498]
Fachinformation Akineton Ret. Stand Jul 2021. [12657]
Fachinformation Aknosan. Stand Feb 2015. [5419]
Fachinformation Aknosan. Stand Feb 2015. [5552]
Fachinformation Akynzeo. Stand Feb 2022. [13104]
Fachinformation Aldactone Lösung. Stand Dec 2018. [8340]
Fachinformation Alecensa. Stand May 2018. [13346]
Fachinformation Alendron Aristo. [14138]
Fachinformation Allegro. Stand Feb 2025. [14278]
Fachinformation Allegro®, Stand der Information: Juli 2008 [2923]
Fachinformation Allopurinol-ratiopharm. [14008]
Fachinformation Allopurinol-ratiopharm. Stand Nov 2018. [13023]
Fachinformation Allopurinol-ratiopharm. Stand Nov 2021. [13232]
Fachinformation Almirid. [10757]
Fachinformation Almirid. Stand Jan 2017. [10760]
Fachinformation Almirid. Stand Jan 2017. [10761]
Fachinformation Almirid. Stand Jan 2017. [10762]
Fachinformation Alna Ocas. Stand Dec 2013. [9241]
Fachinformation Alprazolam Abz. [13412]
Fachinformation Alprazolam Abz. Stand Jul 2018. [10414]
Fachinformation Alversa. Stand Feb 2015. [14207]